Open AccessOral Versus Intravenous Medications for Treatment of Patent Ductus Arteriosus in Preterm Neonates: A Cost-Saving Initiative
Author(s) -
Robert Godin,
Juan Carlos Rodrı́guez,
Doron J. Kahn
Publication year - 2021
Publication title -
the journal of pediatric pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 15
eISSN - 2331-348X
pISSN - 1551-6776
DOI - 10.5863/1551-6776-26.3.291
Subject(s) - medicine , ductus arteriosus , ibuprofen , acetaminophen , pharmacotherapy , retrospective cohort study , emergency medicine , intensive care medicine , pediatrics , anesthesia , surgery , pharmacology
The purpose of the study was to quantify cost savings after promoting oral pharmacotherapy for the treatment of hemodynamically significant patent ductus arteriosus (hsPDA).